GenMark Roche Diagnostics Q1 Sales Climb 50 Percent The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year. GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month. Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally. Roche to Acquire GenMark Diagnostics for $1.8B Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share. Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Feb 26, 2021 GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission Premium Feb 25, 2021 GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales Feb 11, 2021 GenMark Shares Rise on Acquisition Rumors Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Jan 11, 2021 GenMark Diagnostics Preliminary Q4 Revenues Rise 84 Percent on ePlex Molecular Diagnostics Sales Oct 29, 2020 GenMark Diagnostics Expanding Manufacturing to Meet Pent Up Demand for SARS-CoV-2, Respiratory Panel Premium Oct 28, 2020 GenMark Q3 Revenues More Than Double on Respiratory Panel Sales Oct 8, 2020 GenMark Sees Jump in Preliminary Q3 Revenues, Nabs Respiratory Panel FDA Emergency Use Authorization Sep 14, 2020 GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 1, 2020 Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 4, 2020 GenMark Diagnostics Q2 Revenues More Than Double on COVID-19 Testing Jul 7, 2020 GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 1, 2020 Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details May 7, 2020 GenMark Diagnostics, Chembio Diagnostics Price Stock Offerings May 4, 2020 GenMark Diagnostics Q1 Revenues Grow 80 Percent May 1, 2020 GenomeWeb Index Recovers in April as Life Science Industry Focuses on Coronavirus Test Development Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.